1/22/2010

Abaxis, a provider of blood analysis systems, said it has obtained an FDA marketing clearance for its C-Reactive Protein assay. The test, which complements the company's Piccolo Xpress system, can detect infections, inflammatory diseases, tissue injuries and abnormal cell growth in under 12 minutes, Abaxis said.

Full Story:
ABC News

Related Summaries